Lindbrook Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$49.5K Hold
576
﹤0.01% 1014
2024
Q4
$45K Buy
576
+58
+11% +$4.5K ﹤0.01% 859
2024
Q3
$37.3K Hold
518
﹤0.01% 953
2024
Q2
$35.7K Hold
518
﹤0.01% 938
2024
Q1
$37.6K Sell
518
-10
-2% -$669 ﹤0.01% 903
2023
Q4
$32.3K Buy
528
+45
+9% +$2.67K ﹤0.01% 947
2023
Q3
$27.6K Sell
483
-16
-3% -$967 ﹤0.01% 906
2023
Q2
$29.7K Buy
499
+5
+1% +$299 ﹤0.01% 902
2023
Q1
$30.9K Buy
494
+12
+2% +$749 ﹤0.01% 872
2022
Q4
$30.2K Buy
482
+12
+3% +$688 ﹤0.01% 880
2022
Q3
$23K Sell
470
-26
-5% -$1.44K ﹤0.01% 929
2022
Q2
$29K Buy
496
+480
+3,000% +$26.5K ﹤0.01% 853
2022
Q1
$1K Buy
+16
New +$924 ﹤0.01% 2323

Other funds holding PBH

Lindbrook Capital's PBH Position: Q1 2025 in Review

Lindbrook Capital held its Prestige Consumer Healthcare (PBH) position steady in Q1 2025 at 576 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Lindbrook Capital first reported a position in PBH in Q1 2022 and has held it in 13 quarters since. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Lindbrook Capital held 576 shares of Prestige Consumer Healthcare worth $49.5K as of Q1 2025.
  • Lindbrook Capital left its Prestige Consumer Healthcare share count unchanged in Q1 2025.
  • Prestige Consumer Healthcare made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1014 holding.
  • Lindbrook Capital first reported a position in Prestige Consumer Healthcare in Q1 2022 and has held it in 13 quarters since.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.